by Co-Diagnostics | Jan 31, 2020 | News Release
Components of recently designed novel coronavirus assay have successfully passed initial verification Salt Lake City, Utah – January 30, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of...
by Co-Diagnostics | Jan 30, 2020 | News Release
Interviews on Fox Business and other programs discussed issues surrounding the novel strain of the coronavirus and the Company’s plan to provide a diagnostic solution Salt Lake City, Utah – January 30, 2020 – The CEO of Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular...
by Co-Diagnostics | Jan 29, 2020 | News Release
Salt Lake City, Utah – January 29, 2020 – Co-Diagnostics, Inc. (Nasdaq: CODX), was recently featured in an article on BioWorld titled “Co-Diagnostics completes critical step in developing coronavirus diagnostic.” The article discussed completion of principle...
by Co-Diagnostics | Jan 28, 2020 | News Release
Salt Lake City, Utah – January 28, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced...
by Co-Diagnostics | Jan 28, 2020 | News Release
Interview covered method of transmission, importance of accurate diagnostic tools, and the Company diagnostic announced last week Salt Lake City, Utah – January 28, 2020 – The CEO of Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique,...
